课题基金 / 基金详情

Basic and clinical research for perioperative management of braid-death donor and heart transplanted recipient

Basic and clinical research for perioperative management of braid-death donor and heart transplanted recipient
辫子死亡供者与心脏移植受者围手术期处理的基础与临床研究
批准号:
13470320
负责人:
HAYASHI Yukiko
金额:
$7.87万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

HAYASHI Yukiko的其他基金

相似基金

相关文献

中文摘要
翻译
1)按Pratschke等人的方法建立脑死亡模型(大鼠)。(移植67:343-8,1999)和一些修改,我们建立了脑死亡的动物模型。我们的模型可以在脑死亡诱导期间和之后提供更长的血流动力学稳定性。2)脑死亡大鼠挥发性麻醉剂的心肌敏化作用异氟醚和七氟醚对脑死亡大鼠的心肌敏化作用弱于氟烷。然而,与没有任何挥发性麻醉的脑死亡大鼠相比,异氟醚和七氟醚对脑死亡大鼠的心肌敏化作用更强。3)对心律失常的保护作用最小,血流动力学不稳定。三磷酸腺苷敏感钾通道开放剂尼可地尔对心脏移植患者的氟烷肾上腺素心律失常有很强的抗心律失常作用,血流动力学变化很小。4)血流动力学的中枢调节与常规心脏手术患者相比,在中枢神经系统刺激咪唑受体1型对大鼠的氟烷肾上腺素心律失常有抗心律失常的作用。5)心脏移植手术期间血浆肾上腺髓质素水平显著增加,肾上腺髓质素是一种有效的扩张性多肽,在心脏移植患者中,与普通心脏手术患者相比,肾上腺髓质素水平显著升高。提示肾上腺髓质素可能与心肌损伤有关。6)心脏移植麻醉管理中右心功能的监测一种可测量右室射血分数的肺动脉导管在心脏移植麻醉管理中是有效的。
英文摘要
1)Establishment of brain death model (rats)According to the method by Pratschke et al. (Transplantation 67 : 343-8, 1999) and some modifications, we have established the animal model of brain death. Our model can provide longer hemodynamic stability during and following induction of brain-death.2)Myocardial sensitization of volatile anesthetics in brain-dead ratsMyocardial sensitizing effects of isoflurane and sevoflurane are less potent than that of halothane in brain-dead rats. However, both isoflurane and sevoflurane exert more potent myocardial sensitization in brain-dead rats compared with brain-dead rats without any volatile anesthetic.3)Myocardial protection from arrhythmias with minimum hemodynamic instabilityNicorandil, an ATP sensitive potassium channel opener, exerts potent antiarrhythmic effect on halothane-epinephrine arrhythmias with small hemodynamic changes.4)Central regulation of hemodynamicsStimulation of Imidazohne receptor type 1 in the central nervous system provides antiarrhythmic effect on halothane-epinephrine arrhythmias in rats through activation of vagal nerve.5)Adrenomedullin during nerioperative period of heart transplantationPlasma level of adrenomedullin, a potent vasodilating peptide, dramatically increases following separation of cardiopulmonary bypass in patients undergoing heart transplantation compared with patients undergoing usual cardiac operations, suggesting that adrenomedullin maybe related with myocardial injury.6)Monitoring of function of right heart during anesthetic management of heart transplantationA pulmonary artery catheter, which can measure ejection fraction of right ventricle, is effective in anesthetic management of patients undergoing heart transplantation.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
高山あかね, 林行雄, ほか: "心臓移植手術周術期管理におけるスワンガンツCCD/CEDVサーモダイリューションカテーテル^<【○!R】>の使用経験"循環制御. 23. 445-448 (2002)
Akane Takayama、Yukio Hayashi 等:“在心脏移植手术围手术期管理中使用 Swan-Ganz CCD/CEDV 热稀释导管的经验” 循环控制 23. 445-448 (2002)。 )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
林 行雄: "専門医のための麻酔科学レビュー2001"総合医学社. 180-184 (2001)
Yukio Hayashi:“2001 年专家麻醉学评论”Sogo Igakusha 180-184 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takayama A, Hayashi Y, Yamano R, Iwasaki M, Kamibayashi T, Mashimo T.: "Utility of the Swan-Ganz CCO/CEDV thermodilution catherter <R○>^の during anesthetic management of heart transplantation.(In Japanese)"Circ Cont. 23. 445-448 (2002)
Takayama A、Hayashi Y、Yamano R、Iwasaki M、Kamibayashi T、Mashimo T.:“心脏移植麻醉管理期间 Swan-Ganz CCO/CEDV 热稀释导管 <R○>^ 的实用性。(日语)”Circ Cont . 23. 445-448 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakatani T, Sasako Y, Hanatani A, Kobayashi J, Bando K, Ono Y, Nowata K, Tag sari O, Komamura K, Kimono K, Yagihara T, Miyatake K, Kitamura S.: "Cardiopretection for heart failure therapy. Surgical therapy for end-stage heart failure (Left ventricular ass
Nakatani T、Sasako Y、Hanatani A、Kobayashi J、Bando K、Ono Y、Nowata K、Tag sari O、Komamura K、Kimono K、Yagihara T、Miyatake K、Kitamura S.:“心力衰竭治疗的心脏保护。手术治疗
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    To elucidate pathomechanisms of myopathies associated with nuclear envelopathy
    Epigenomics and muscular dystrophy
    Clinical and molecular studies of Emery-Dreifuss muscular dystrophy
    Clinical and molceulcar analyses of facioscpubhumeral muscular dystrophy
    海外基金